Dow Jones 12108.43 +5.13 2:55 pm PST, November 10, 2006 NASDAQ 2389.72 +13.71 For info, visit access.smallcapnetwork.com S & P 500 1380.90 +2.57 Change your subscription status here Russell 2000 769.15 +7.09 VOLUME 06: ISSUE 90 Whatever Happened To.... With all the new trading ideas we've been finding for you, we haven't had much of a chance to revisit some of older ones. Well that's going to change today though, as we review some of the names we haven't touched on in a while. We think you may find some renewed opportunity now that the earnings dust is starting to settle. No need for chatter - let's just dig right in.   Will The Third Time Be The Charm For Clearly Canadian? Are Clearly Canadian Beverage Corp. (OTCBB: CCBEF) shares establishing a triple-bottom? We think they might be, although only time will really tell. The 20 day moving average line (blue) appears to have guided the stock lower after it topped out in June at $4.55, but over the course of the last three months, we've also observed a support floor (orange) between $2.10 and $2.20.  Even though we think the resistance at the 20 day line would be the most immediate worry for the bulls, we also think there's more brewing at the $2.10 area than a mere coincidence. After all, this downtrend has had three chances to push shares under that line, with the third attempt still in the works. Like we said, only time can really tell where this chart is headed next, but we'd be amiss if we didn't at least offer the idea that a triple-bottom here could possibly lead to a recovery effort. If it is indeed a triple-bottom - and we think we should know within a handful of days - then we feel it could make the current level an attractive entry area for so-inclined speculators.    Tech, Tech, and More Tech You know how we've said recently a company's performance isn't always necessarily reflected on its stock's chart? We think On The Go Technologies (OTCBB: ONGO) may be a fine example of the idea. However, we also know the disconnection is rarely permanent - an important idea, we feel, for anyone interested in ONGO shares.  What got our attention? Big buying volume on Thursday, apparently out of nowhere. We saw 172,000 shares exchange hands that day, which was the single biggest volume day we've ever seen for On The Go. With shares moving up by 12.7% on that high volume, we think something significant could be going on.  In the interest of a complete opinion, we still think this stock includes substantial risk. And, a quick glance at its recent history verifies the concern, as the chart has moved from $10 in June to 89 cents as of today. However, in our opinion, the best time to own shares can be when hardly anyone else seems interested. Fundamentally, the company is making positive strides, so a potential catalyst is in place. And, we feel there may be other buyers just biding their time to scoop up a stock that's 90% lower than where it was just five months ago, especially if the company can continue to build on its trend towards profitability. While there's still some technical damage that would need to be undone, we feel On The Go's recent leveling off at new lows could provide risk-tolerant speculators an interesting opportunity.  Commerce Planet (OTCBB: CPNE) has actually been covered pretty well of late, so we don't want to be repetitive. But, there are a couple of things about the chart we feel are well worth noting...regardless of their incredible revenue and earnings performance.  First, and perhaps foremost, the 50 day moving average (orange) may well be the line in the sand for some traders. Although shares traded under that level briefly over the last three weeks, by and large, we think it's held up as support. In our opinion, this bodes well for the stock. And it doesn't hurt that they saw big earnings and revenue increases last quarter, which we've seen prod some buying in the past. Second, for shorter-term traders, we feel the 3x3 displaced moving average (blue) has been an effective tool to spot all the chart transitions from 'zig' to 'zag'. Currently, it's at $1.48, versus shares being at $1.45. We think it's a tool worth utilizing if you have a charting program with the feature.  Our Web2 Corp. (OTCBB: WBTO) profile was only issued a few weeks ago because, for all practical purposes, the company was only launched a few weeks ago. Although the stock has been trading since 2004, the company was still building its revenue modules until very recently. In fact, we covered the beginnings of their Chamber of E-Commerce, and ByIndia.com.  What's that got to do with anything? If you're hesitant to buy the stock of a company with no revenue, we can't say we entirely blame you. But on the flip side, we also have to point out that may not be the situation with Web2 Corp. anymore - the company is up and running now. If you liked the direction Web2 Corp. was headed in our other commentary, and if you think those fundamentals will eventually show up in the stock's trading level, then we feel the current price of about $1 may be attractive to you. It's at the lower end of the short-term range, and close to being an all-time low.    Sporting Goods, From Boards to Boats Execute Sports (OTCBB: EXCS), in our opinion, remains one of the better opportunities out there for speculators. We've watched the company develop some major partnerships, acquire all sorts of talented people, and go out and grow revenue. Yet, this stock hasn't gotten much if any love this year. Well, we're not saying things have changed just yet for the stock, but there's a noticeable shift in volume...to the buying side. On the nearby chart, we're now seeing a lot more (and taller) green volume bars. Does somebody know something? Could be, or maybe the right investors have finally started seeing the same things we've been seeing.  The potential trump card, we feel, is resistance again at the 20 day moving average line (purple). It's at 6.1 cents right now, compared to EXCS's trading level of 4 cents. All the same, our take is that it's an opportunity at least worth monitoring.  Xtreme Companies (OTCBB: XTME) shares may not have had the strongest summer, but if this stock fell off your radar, we think you might want to consider putting it back on. While XTME hasn't had much luck in moving higher again just yet, it's not falling anymore...which we think is at least a good start on the road to a rebound. The 3.5 cent area seems to be the happy medium between the sellers and buyers right now.  So why our renewed interest in what looks like a sideways trend? There are some underlying things happening that got our attention. In October we saw a relatively big 'accumulation' day, and then another one in November. And for the first time in months, we're starting to see meaningful trading activity above the 50 day line (blue). Subtle, and arguable? Yes to both. However, we still think it's worth watching to see if anything comes of it. After all, this performance-boat company appears to have a viable turn-around plan in the works.    Last But Not Least, Today's Only Biotech  BioCurex Inc. (OTVBB: BOCX) shares may finally be in a bullish mode again, at least from our interpretation of the chart. From our point of view, the higher highs and higher lows framed by the blue support and resistance lines on the nearby chart suggest this stock could be getting primed for a recovery. Granted, the trip back and forth between those lines could make you seasick, but on the other hand, this is probably the kind of chart most 'traders' live for. Note that almost every reversal within that framework has coincided with a stochastically overbought or oversold situation. If the pattern is still in place, then we feel it's possible the recent support at the lower line could be providing an attractive opportunity.  What's not quite as evident on the chart is the longer-term support we've observed around the 50 cent level. Not only was it the absolute bottom so far for 2006 (not once, but twice), we also saw BOCX bottom there twice in 2004. Based on the history this stock seems to have with that line, it's possible that the July and August lows at the same mark could have even bigger bullish implications than the short-term trading range we've plotted.  There are a few more companies we've still got on our radar that we didn't have space to cover today, so look for those in an upcoming edition. In the meantime, have a great weekend!      We Value Your Feedback   Got comments, questions or suggestions? Send 'em on over: Editor@smallcapnetwork.com If you wish to send a written request or inquiry, please send it to our physical address: TGR Group, LLC 4653 Carmel Mtn Rd Suite 308 #402 San Diego, CA 92130 Your Advocacy Requested in the War on Cancer As many of you may know, one of our profiled companies, CEL-SCI (AMEX: CVM), has developed an amazingly effective cancer treatment called Multikine. In Phase I and Phase II testing, the treatment has been proven to be very effective.  Unfortunately, Multikine has yet to be approved for Phase III trials in the United States - the final phase in the FDA approval process. It has been waiting on Phase III approval for 22 month. By comparison, the Canadian equivalent to the FDA approved Phase III trials just two months after filing the request.  In the meantime, U.S. cancer patients whose only hope may be Multikine are dying, having never even been able to attempt the experimental treatment. They're dying while waiting on a bureaucracy to just allow a wider-scale, more in-depth Phase III trials.  Whether or not you own, or plan to own, CEL-SCI shares is irrelevant. This isn't about money. This is about medical progress that can possibly save lives....perhaps that of a family member, perhaps yours.  There is something you can do.  Click here for specific details on the situation, and tolearn how to write in to the FDA Commissioner and urge a rapid decision on Phase III testing.    Immune Response Extends Warrant Time Frame Immune Response (OTCBB: IMNR) announced this week the second set of warrants, issued through their March financing, would be extended past their original expiration date of November 30th. The same warrants will now expire on March 1st, 2007.  This tranche of warrants - the second set established by the deal set up earlier in the year - could potentially inject $12,000,000 into the company's operating fund via the sale of up to 600 million shares, at 2 cents each. Each share issued through the warrants would be a newly issued share, adding to the current float of about 850 million shares.  As for what it means to investors, click here to read our opinion.   Healthcare Stocks Not Looking Too Healthy To Us Although slightly off our beaten path of 'strictly small cap', we thought this observation could still possibly make you - or at least save you - some money.....we don't think healthcare is such a great place to be right now.  This sector is dragging the bottom in the 2-week and 1-month time frames. It's only ahead of two other sectors (energy and utilities) in a 3-month timeframe, and is next to last in the 52-week performance column. A chart of the S&P Healthcare Sector Index (HCX) verified our suspicions. Click here to take a look.  Note that there is one major exception to this broad healthcare weakness, but you'll have to click the link to see what it is.    Commerce Planet Nails Earnings Three-Peat Well, as we expected, Commerce Planet (OTCBB: CPNE) saw a huge earnings increase.....again.  The Planet finally released the news on Monday morning. They saw $9.7 million in sales in their Q3, with $3.1 million in profits. For the same quarter last year, they only posted $1.7 million in sales, and lost $2.1 million.  Equally impressive is the increase in margin. Clearing $1.4 million on $7 million in sales last quarter translates into a margin of 20%. The $3.1 million in cleared earnings on 9.7 million in sales this quarter means profit margins went to 32%. Wow!  For the full details, click here.  Subscribe Information is power and timely information is profitable. Become informed and profit from SmallCapDigest Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the SmallCapDigest Email Newsletter on a regular basis. To ensure newsletter delivery, you can add any additional email addresses you may have to the SmallCapDigest Member List. Receiving the SmallCapDigest Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the SmallCapDigest recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery. Subscribe Here Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the SmallCapDigest, simply follow the instructions located at the bottom of every SmallCapDigest Newsletter Edition. Unsubscribe Here D I S C L A I M E R: The Small Cap Digest, the Small Cap Network, its website and email newsletter (hereafter, cumulatively referred to as "SCD") , is an independent electronic publication committed to providing its readers with factual information on select publicly traded companies. SCD is owned and operated by TGR Group, LLC ("TGR"). TGR is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.  Moreover, as detailed below, TGR accepts compensation from third party consultants and/or companies, which it features in the publication and circulation of SCD. To the degrees enumerated herein, SCD should not be regarded as an independent publication.  Click Here or go to http://access.smallcapnetwork.com/compensation_disclosure.html to view our compensation on every company we have ever covered, or visit the following web address: http://www.smallnetwork.net/profile_disclosure.html for our full profiles and http://access.smallcapnetwork.com/short_term_alerts.html for Trading Alerts.  TGR Group, LLC has been paid a fee of $30,000 cash and 20,000 shares (reverse split adjusted 08/09/06) of newly issued, restricted stock by On the Go Technologies Group for coverage of the Company. TGR Group LLC has been paid a fee of $30,000 and 200,000 newly issued restricted shares of Network Installation for coverage of the company. In addition, one of the principles of TGR Group LLC is also a principle of MarketByte LLC. In a separate contractual relationship in 2003, MarketByte LLC was paid a fee of $25,000 in cash and 500,00 newly issued, restricted shares by Network Installation for coverage of the company. The term of MarketByte's obligation to Network Installation has expired. The aforementioned 500,000 shares issued to MarketByte LLC have become free trading, and whatever number remains could be sold at anytime. This should be viewed as a potential conflict of interest. TGR Group LLC has been paid a fee of $30,000 and 300,000 newly issued restricted shares by Execute Sports for coverage of the company. In addition, one of the prinicipals of TGR Group purchased 100,000 shares of Execute Sports at a cost of $.25 per share prior to the public offering. The shares are now eligible to be free trading.That individual may choose to sell the shares at any time. This should be viewed as a potential conflict of interest. TGR Group LLC has been paid a fee of $60,000 by Commerce Planet for coverage of the company. In addition, one of the principles of TGR Group LLC is also a principle of MarketByte LLC. In a separate contractual relationship in 2004, MarketByte LLC was paid a fee of $25,000 in cash and 750,000 newly issued, restricted shares by Commerce Planet for coverage of the company. The aforementioned shares are all currently eligible to be free trading. The term of MarketByte's obligation to Commerce Planet has expired. TGR Group LLC has been paid a fee of $30,000 and pledged 150,000 warrants with an exercise price of $2, currently convertible into restricted shares of Clearly Canadian, by Level III Research, for its coverage of Clearly Canadian. TGR Group LLC has been paid a fee of $25,000 and 150,000 shares of newly issued restricted stock by Cel-Sci for coverage of the Company. Additionally, back in November of 2002, TGR Group LLC was paid a fee of $25,000 and 250,000 shares of newly issued restricted stock of Cel-Sci for coverage of the company until November of 2003. The aforementioned 250,000 restricted shares became free trading under SEC rule 144 and were sold in the open market prior to the company entering into a new contract agreement with TGR Group in February of 2006. TGR Group LLC has been paid a fee of $25,000 cash and 500,000 shares of newly issued restricted stock directly by Xtreme Companies for coverage. The aforementioned shares have become free trading under Rule 144. On March 7, 2006, TGR Group LLC entered into a contract extension whereby TGR could receive as much as $65,000 cash and 1 million, newly issued restricted shares over the next one year period from Xtreme for coverage of the company. To date, TGR has received an additional $20,000 and 250,000 newly issued restricted shares. In October of 2003, TGR Group LLC was paid a fee of $25,000 and one million newly issued restricted shares by Biocurex for coverage of the Company. Under SEC Rule 144, all one million issued restricted shares have been eligible for sale into the public market since October of 2004. In addition, on March 22, 2005, TGR entered into an extended agreement with Biocurex for a fee of 25,000 newly issued restricted shares and on July 1, 2006 TGR entered into another extended agreement with Biocurex for an additional 100,000 shares of newly issued, restricted stock. TGR Group, LLC has been paid a fee of $30,000 cash and 10 Million shares of newly issued restricted stock by Immune Response Corp. for coverage of the Company.  TGR Group, LLC has been paid a fee of $25,000 cash and 75,000 shares of newly issued restricted stock by Web2 Corp. for coverage of the Company. From time to time TGR sells shares received as compensation for coverage of client companies. Shares received are sold in the open market. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, TGR does not view the sale of the shares as contradictory to any opinions delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.  TGR, its Members and Members' families, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed.  All statements and expressions are the sole opinions of TGR and are subject to change without notice. A profile, description, or other mention of a company within SCD is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.  THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF TGR.  We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.